N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer —A Longitudinal Cohort Study Based on German Health Insurance Data
CONCLUSION: These findings suggest that the consumption of NDMA-contaminated valsartan is associated with a mildly increased risk of hepatic cancer, but no association was found with the risk of cancer overall. Close observation of the potential long-term effects of NDMAcontaminated valsartan seems advisable.PMID:33632389 | DOI:10.3238/arztebl.m2021.0129
Source: Deutsches Arzteblatt International - Category: General Medicine Authors: Willy Gomm Christoph R öthlein Katrin Sch üssel Gabriela Br ückner Helmut Schr öder Steffen Hess Roland Fr ötschl Karl Broich Britta Haenisch Source Type: research
More News: Cancer | Cancer & Oncology | Diovan | General Medicine | Germany Health | Health Insurance | Insurance | Statistics | Study